Using molecular breast imaging to guide breast biopsies
Part of Cancer, Skin clinical trials.
This study uses molecular breast imaging (MBI) to help guide biopsies for women with breast abnormalities. It has two parts: one for women with past MBI findings that turned out to be benign, and another for women who need a biopsy now based on recent imaging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You are not pregnant and can have a pregnancy test if needed
- You do not have breast implants in the breast being studied
- You are not currently breastfeeding or stopped less than 2 months ago
- You can provide your written consent to participate
- Part I: You had an MBI study in the last 3 years with a finding later shown to be benign
- Part II: You have a breast finding on recent imaging that needs a biopsy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a breast imaging method called molecular breast imaging (MBI) to help guide a biopsy for women with dense breasts. It may help doctors more accurately sample suspicious areas in dense tissue.
This study compares two ways of imaging the breast—molecular breast imaging (a scan that uses a small radioactive tracer) and standard breast MRI—to better find or rule out breast cancer. You may join if you are considered high risk and already have a breast MRI planned, and you can do both tests close together.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This trial tests a new Feminai device that maps breast tissue to find suspicious lumps. If you're coming for a routine mammogram or a biopsy, this could help improve detection.
This study is testing whether a special MRI scan can help show tiny features inside breast tumors (TMEM). It’s mainly a “feasibility” study, meaning the team is checking if the scan can be done safely and clearly in different types of operable breast cancer.
This study tests selected treatment decisions for women with early-stage breast cancer that has certain lab test results. It may help researchers better match care using MRI and tumor marker information.
Hear when a new Breast Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.